PortfoliosLab logoPortfoliosLab logo
ISIN
US44930G1076
CUSIP
44930G107
IPO Date
Mar 31, 1992

Highlights

Market Cap
$3.29B
Enterprise Value
$4.30B
EPS (TTM)
$1.89
PE Ratio
68.99
PEG Ratio
1.62
Total Revenue (TTM)
$2.16B
Gross Profit (TTM)
$817.30M
EBITDA (TTM)
$247.33M
Year Range
$107.00 - $160.29
Target Price
$163.50
ROA (TTM)
1.17%
ROE (TTM)
2.22%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ICU Medical, Inc.

Performance

ICUI Performance Chart

ICU Medical, Inc. (ICUI) is down 8.5% since the beginning of the year. At $131 per share, ICUI is trading 18.6% below its 52-week high of $160. Investors who bought $1,000 worth of ICUI shares 5 years ago would now be looking at an investment worth $634.


Loading charts...

S&P 500 Index

Returns By Period

ICU Medical, Inc. (ICUI) has returned -8.52% so far this year and -0.02% over the past 12 months. Over the last ten years, ICUI has returned 2.23% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.


ICU Medical, Inc.

1D
0.03%
1M
9.99%
YTD
-8.52%
6M
-9.39%
1Y
-0.02%
3Y*
-10.89%
5Y*
-8.71%
10Y*
2.23%

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ICUI Monthly Returns History

Based on dividend-adjusted daily data since Mar 31, 1992, ICUI's average daily return is +0.08%, while the average monthly return is +1.36%. At this rate, an investment would double in approximately 4.3 years.

Historically, 53% of months were positive and 47% were negative. The best month was Jan 1993 with a return of +50.0%, while the worst month was Jun 1996 at -37.4%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 8 months.

On a daily basis, ICUI closed higher 48% of trading days. The best single day was Sep 8, 2021 with a return of +26.2%, while the worst single day was Aug 8, 2019 at -33.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20265.07%0.45%-14.23%-7.70%13.58%-3.60%-8.52%
20255.92%-10.97%-5.10%-1.63%-1.27%-2.01%-2.83%-0.58%-6.03%0.11%23.61%-3.89%-8.06%
2024-8.23%19.34%-1.75%-8.76%8.60%11.67%6.93%30.20%10.22%-6.31%-3.97%-5.36%55.57%
202322.70%-11.69%-3.33%14.66%-7.53%1.89%-0.01%-18.60%-17.94%-17.60%-10.50%13.65%-36.66%
2022-10.10%10.95%-5.95%-3.89%-15.12%-9.50%7.77%-10.26%-5.28%-1.45%7.29%-1.10%-33.65%
2021-4.67%1.48%-0.99%1.38%-0.10%-1.09%-1.22%-1.94%17.07%0.32%-3.38%4.92%10.65%

Benchmark Metrics

ICU Medical, Inc. has an annualized alpha of 13.44%, beta of 0.66, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since April 01, 1992.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (81.08%) than losses (72.10%) - typical of diversified or defensive assets.
  • Beta of 0.66 may look defensive, but with R2 of 0.08 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
13.44%
Beta
0.66
0.08
Upside Capture
81.08%
Downside Capture
72.10%

Return for Risk

Risk / Return Rank

ICUI ranks 39 for risk / return — below 39% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


ICUI Risk / Return Rank: 3939
Overall Rank
ICUI Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
ICUI Sortino Ratio Rank: 3737
Sortino Ratio Rank
ICUI Omega Ratio Rank: 3737
Omega Ratio Rank
ICUI Calmar Ratio Rank: 4141
Calmar Ratio Rank
ICUI Martin Ratio Rank: 4141
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for ICU Medical, Inc. (ICUI) and compare them to S&P 500 Index.


ICUIBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.24

Sortino ratioReturn per unit of downside risk

-2.81

Omega ratioGain probability vs. loss probability

1.03

1.41

-0.37

Calmar ratioReturn relative to maximum drawdown

-0.00

2.93

-2.93

Martin ratioReturn relative to average drawdown

-0.00

13.52

-13.52

Dividends

Dividend History


ICU Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the ICU Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ICU Medical, Inc. was 73.82%, occurring on Nov 9, 2023. The portfolio has not yet recovered.

The current ICU Medical, Inc. drawdown is 57.86%.


Related event

Drawdown

Fall

Recovery

Underwater

2023 bear market2023
-73.82%Nov 2023
5y 4mo
7y 11moJun 2018 - now
1996 bear market1996
-71.81%Oct 1996
4mo 11d3y 8mo
4y 15dJun 1996 - Jun 2000
Financial crisis2007–2009
-53.08%Jun 2008
1y 8mo3y 9mo
5y 5moOct 2006 - Mar 2012
2004 bear market2004
-49.92%Nov 2004
1y 11mo1y 10mo
3y 9moNov 2002 - Aug 2006
1993 bear market1993
-47.83%Jun 1993
2mo 10d7mo 13d
9mo 23dApr 1993 - Jan 1994

Drawdown Indicators


ICUIBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-73.82%

-56.78%

-17.04%

Max Drawdown (1Y)

Largest decline over 1 year

-27.18%

-9.10%

-18.08%

Max Drawdown (3Y)

Largest decline over 3 years

-58.22%

-18.90%

-39.32%

Max Drawdown (5Y)

Largest decline over 5 years

-68.82%

-25.43%

-43.39%

Max Drawdown (10Y)

Largest decline over 10 years

-73.82%

-33.92%

-39.90%

Current Drawdown

Current decline from peak

-57.86%

-0.74%

-57.12%

Average Drawdown

Average peak-to-trough decline

-25.75%

-10.72%

-15.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.14%

1.97%

+10.17%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of ICU Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how ICU Medical, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for ICUI, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, ICUI has a P/E ratio of 69.0. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for ICUI compared to other companies in the Medical Instruments & Supplies industry. ICUI currently has a PEG ratio of 1.6. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ICUI relative to other companies in the Medical Instruments & Supplies industry. Currently, ICUI has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ICUI in comparison with other companies in the Medical Instruments & Supplies industry. Currently, ICUI has a P/B value of 1.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with ICUI

Add ICU Medical, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with ICUI